跳至主要内容
临床试验/NCT07125014
NCT07125014已完成不适用

Frequency and Risk Factors of Post-ERCP Pancreatitis: A Single-Center Experience From South Asia

Nangarhar University1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2023年1月1日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
300
试验地点
1
主要终点
Incidence of Post-ERCP Pancreatitis

研究概览

简要总结

This study was conducted at the Department of Gastroenterology, Lady Reading Hospital, Peshawar, Pakistan, from January 2023 to December 2023. It aimed to determine how often patients develop pancreatitis (inflammation of the pancreas) after undergoing a procedure called endoscopic retrograde cholangiopancreatography (ERCP), and to identify the main factors that increase this risk. We reviewed the medical records of 300 adult patients who had ERCP for various conditions, such as bile duct stones, tumors, and strictures. We assessed patient characteristics, procedure details, and laboratory results to see which factors were linked to post-ERCP pancreatitis. The study found that prolonged cannulation time, injection of contrast into the pancreatic duct, and high levels of C-reactive protein before the procedure were the strongest predictors of this complication. These findings may help doctors identify high-risk patients and take preventive steps to reduce the chances of pancreatitis after ERCP.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Known chronic pancreatitis
  • Pancreatic malignancy
  • Pre-existing acute pancreatitis
  • Incomplete procedural or laboratory records

排除标准

  • Known chronic pancreatitis
  • Pancreatic malignancy
  • Pre-existing acute pancreatitis
  • Incomplete procedural or laboratory records

结局指标

主要结局

Incidence of Post-ERCP Pancreatitis

时间窗: Within 24 hours after ERCP and during hospitalization

The number and proportion of patients developing post-ERCP pancreatitis (PEP), defined as new or worsened abdominal pain with serum amylase or lipase levels ≥3 times the upper limit of normal within 24 hours after ERCP, requiring hospitalization or prolongation of hospital stay.

次要结局

未报告次要终点

研究者

发起方
Nangarhar University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Rafiullah Hotak

Doctor

Nangarhar University

研究点 (1)

Loading locations...

相似试验